| 1 Reduction of keloid scar size by 50% |
1 |
34 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.13 [0.03, 0.46] |
| 2 Improvement in erythema |
1 |
34 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.1 [0.01, 0.70] |
| 3 Symptomatic relief of itching and pain |
1 |
18 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.6 [0.20, 1.79] |
| 4 Average time (in days) to improvement |
1 |
28 |
Mean Difference (IV, Fixed, 95% CI) |
‐2.9 [‐3.93, ‐1.87] |
| 5 Patient preference |
1 |
28 |
Risk Ratio (M‐H, Fixed, 95% CI) |
5.5 [1.48, 20.42] |
| 6 Development of complications |
1 |
28 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.1 [0.01, 0.68] |